Japan - Healthcare, Regulatory and Reimbursement Landscape

Publisher Name :
Date: 15-Apr-2021
No. of pages: 167
Inquire Before Buying

Japan - Healthcare, Regulatory and Reimbursement Landscape

Summary

GlobalData, the industry analysis specialist, has released its latest report, "Japan - Healthcare, Regulatory and Reimbursement Landscape". The report is an essential source of information on analysis of the healthcare, regulatory and reimbursement landscape in Japan. It identifies the key trends in the country's healthcare market and provides insights into its demographic, regulatory and reimbursement landscape, and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData's team of industry experts.

The Japanese pharmaceutical market is the third largest in the world in terms of value. Japan's pharmaceutical market, based on production value, increased from ¥6,894B in 2013 to ¥9,281B in 2020 at a Compound Annual Growth Rate (CAGR) of 4.34%. In terms of US Dollars, the market increased from $70.64B in 2013 to $86.96B in 2020 at a CAGR of 3.01%. It is forecast to reach about $100.88B in 2025. The increasing elderly population, chronic and lifestyle diseases, incentives for innovation, and short regulatory approval timelines are the main factors driving the growth of the Japanese pharmaceutical market.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Japan, and includes -

- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers

- Profiles and SWOT analyses of the major players in the pharmaceutical market: Pfizer, Novartis, GSK, Takeda, and Astellas Pharma

- Profiles and SWOT analyses of the major players in the medical device market: Medtronic, Siemens Healthineers, DePuy Synthes, Olympus, and Terumo

- An insightful review of the COVID-19 epidemiology, COVID-19 impact, and developments in healthcare market, HealthTech landscape, reimbursement, and regulatory landscape, with analysis covering details of the country's healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices

- Detailed analysis of the country's healthcare policy highlights, demographics, healthcare infrastructure, and healthcare expenditure

- An overview of the opportunities for and challenges to growth in the Japanese healthcare market

Reasons to Buy

This report will enhance your decision-making capability by allowing you to -

- Develop business strategies by understanding the trends shaping and driving Japan's healthcare market

- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact Japan's healthcare market in the future

- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors' performance

- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership

Japan - Healthcare, Regulatory and Reimbursement Landscape

1. Table of Contents
1.1 List of Figures
1.2 List of Tables
2. Executive Summary
2.1 Executive Summary
2.2 Key Highlights - Facts about the Japanese Healthcare Market
2.3 Key Highlights: Healthcare Startups in Japan
2.4 Key Events: Japanese Healthcare Timeline, 2014-2020
2.5 Key Events: Japanese Pharmaceutical Market
2.6 Key Events: M&As, VC & PE Deals, Global Pharmaceutical Market, 2019-2020
2.7 Key Events: Mergers and Acquisitions
2.8 Country Profile, Japan, 2020
3. Overview of Pharmaceutical Market
3.1 Pharmaceutical Market - Overview
3.2 Pharmaceutical Market - Exports
3.3 Pharmaceutical Market - Imports
3.4 Pharmaceutical Market - Supply Channels, Japan
3.5 Pharmaceutical Market - Market Segments
3.6 Major Therapeutic Areas, Japan
3.7 COVID-19 Epidemiology, Japan
3.8 COVID-19 Impact and Developments in the Healthcare Market, Japan
3.9 COVID-19 Clinical Trials Landscape, Japan
3.10 Pharmaceutical Market - Major Players
4. Overview of Medical Devices Market
4.1 Medical Device Market - Overview
4.2 Medical Devices Market - Major Players
5. Pharmaceutical and Medical Devices Market - Drivers and Barriers
5.1 Drivers
5.2 Barriers
6. Deal Analysis
6.1 Deal Analysis: Pharmaceutical Market, Japan, 2020-2021
6.2 Deal Analysis: Medical Device Market, Japan, 2020-2021
7. HealthTech Landscape
7.1 HealthTech Landscape, Japan
7.2 HealthTech Deals Landscape, Japan
7.3 Key HealthTech Deals, Japan
7.4 Adoption of Technology in Healthcare, Japan
7.5 Key Development Technologies, Japan
7.6 Regulatory Scenario Covering Use of Technology in Healthcare, Japan
7.7 HealthTech Landscape: Benefits and Risks, Japan
8. Market Access
8.1 Overview of Healthcare System, Japan
8.2 Reimbursement Process, Japan
8.3 Overview of Insurance Providers, Japan
8.4 Healthcare Spending and Prescription Drug Price Trend, Japan
8.5 Pricing Policies, Japan
8.6 Regulatory Landscape, Japan
8.6.1 Overview of Regulatory Agencies
8.6.2 Marketing Authorization for Pharmaceutical Products, Japan
8.6.3 Marketing Authorization for Medical Devices, Japan
8.6.4 Marketing Authorization for Regenerative Medical Products, Japan
8.6.5 Intellectual Property Rights, Patent, Japan
8.6.6 Intellectual Property Rights, Trademark, Japan
8.6.7 Clinical Trial Regulation Process, Japan
8.6.8 Pharmaceutical Clinical Trials Landscape, Japan
8.6.9 Medical Devices Clinical Trials Landscape, Japan
8.6.10 Market Authorization for Pharmaceutical Manufacturing, Japan
8.6.11 Market Authorization for Medical Devices Manufacturing, Japan
8.6.10 Pharmaceutical Export and Import, Japan
8.6.13 Pharmaceutical Advertisement Regulations, Japan
8.6.14 Pharmacy Regulations, Japan
8.6.15 Labeling and Packaging Regulations, Japan
9. Country Healthcare Landscape
9.1 Japanese Healthcare Policy Highlights
9.2 Healthcare Facilities, Japan
9.3 Healthcare Parameters, Japan
9.4 Life Expectancy and Immunization Rate, Japan
9.5 Environmental Health, Japan
9.6 Healthcare Personnel, Japan
9.7 Disease Burden, Japan
9.8 Healthcare Expenditure, Japan
10 Trade Associations, Japan
11 Trade Fairs, Japan
12 Opportunities and Challenges
13 Appendix
13.1 Research Methodology
13.1.1 Coverage
13.1.2 Secondary Research
13.1.3 Forecasts
13.2 Bibliography
13.3 About GlobalData
13.4 Contact Us
13.5 Disclaimer

List of Tables
Table 1: Biopharmaceuticals Composition Ratio (%), Japan, 2019
Table 2: Approved Biosimilars, Japan, 2017-2021
Table 3: Major Therapeutic Areas by Production Value ($B), Japan, 2019
Table 4: COVID-19 Indicators (Number of Cases), Global and Japan, 2020-2021
Table 5: COVID-19-Related Travel Restrictions, Japan, 2020-2021
Table 6: COVID-19 Vaccines Development Landscape, Japan, 2020-2021
Table 7: Approved Medical Products for COVID-19, Japan, 2020-2021
Table 8: Approved Medical Devices for COVID-19, Japan, 2020-2021
Table 9: COVID-19 IVD Products (April ‘20- April ‘21), Japan, 2020-2021
Table 10: Medical Device Market, Japan, Major Segments ($B), 2020
Table 11: General Surgery Market, Japan, Revenue ($M) and Market Share (%) of Major Companies, 2019
Table 12: Orthopedic Devices Market, Japan, Revenue ($M) and Market Share (%) of Major Companies, 2019
Table 13: Cardiovascular Devices Market, Japan, Revenue ($M) and Market Share (%) of Major Companies, 2019
Table 14: Wound Care Management Market, Japan, Revenue ($M) and Market Share (%) of Major Companies, 2019
Table 15: Nephrology and Urology Devices Market, Japan, Revenue ($M) and Market Share (%) of Major Companies, 2019
Table 16: Medical Device Reimbursement Assessment Categories, Japan, 2018
Table 17: Public Insurance Schemes, Japan, 2019
Table 18: Types of Premiums, Japan, 2020
Table 19: Classification and Regulation Regarding Medical Devices, Japan, 2021
Table 20: Classification of Regenerative Medical Products, Japan, 2021
Table 21: Patent Fees, Japan, 2021
Table 22: Trademark Fees, Japan, 2021
Table 23: Headings and their Sequence in Package Inserts, Japan, 2021

List of Figures
Figure 1: Pharmaceutical Market, Japan, Revenue ($B and ¥B), 2013-2020
Figure 2: Medical Device Market, Japan, Revenue ($B), 2015-2020
Figure 3: Healthcare Startups in Japan, 2021
Figure 4: Number of Deals (2019-2020)
Figure 5: 2019-2020 Deal Overview by Region
Figure 6: Country Profile, Japan, 2020
Figure 7: Pharmaceutical Market, Japan, Revenue ($B and ¥B), 2013-2020
Figure 8: Pharmaceutical Market, Japan, Revenue Forecast ($B and ¥B), 2021-2025
Figure 9: AMED Projects, Japan, 2019
Figure 10: Pharmaceutical Exports ($B), Japan, 2013-2020
Figure 11: Top Export Partners, Japan, 2020
Figure 12: Pharmaceutical Imports ($B), Japan, 2013-2020
Figure 13: Top Import Partners, Japan, 2020
Figure 14: Pharmaceutical Supply Channel, Japan, 2021
Figure 15: Generic Drugs Penetration Rate, Japan, 2005-2018
Figure 16: Pharmaceutical, Biotechnology, and Healthcare Clusters, Japan, 2021
Figure 17: OTC Medicines Market, Revenue ($B), Japan, 2013-2020
Figure 18: OTC Medicines Market, Major Distribution Channels ($B), Japan, 2020
Figure 19: OTC Medicines Market, Major Categories ($B), Japan, 2020
Figure 20: Major Therapeutic Areas by Production Value, Japan, 2019
Figure 21: COVID-19 Cases, Japan, 2020-2021
Figure 22: COVID-19 Deaths, Japan, 2020-2021
Figure 23: COVID-19 Fiscal Stimulus Timeline, Japan, 2020-2021
Figure 24: COVID-19 Vaccination Progress, Japan, 2021
Figure 25: COVID-19 Clinical Trials Count by Phase, Japan, 2020-2021
Figure 26: COVID-19 Clinical Trials Count by Trial Status, Japan, 2020-2021
Figure 27: Top Five COVID-19 Clinical Trials Sponsors by Trial Count, Japan, 2020-2021
Figure 28: Medical Devices Market, Japan, Revenue ($B), 2015-2020
Figure 29: Medical Devices Market, Japan, Revenue Forecast ($B), 2021-2025
Figure 30: AMED Projects for Medical Device, Japan, 2020
Figure 31: Medical Device Market, Japan, Major Segments (%), 2020
Figure 32: General Surgery Market, Japan, Revenue ($B), 2017-2025
Figure 33: General Surgery Market, Japan, Market Share of Major Players (%), 2019
Figure 34: Orthopedic Devices Market, Japan, Revenue ($B), 2017-2025
Figure 35: Orthopedic Devices Market, Japan, Market Share of Major Players (%), 2019
Figure 36: Cardiovascular Devices Market, Japan, Revenue ($B), 2017-2025
Figure 37: Cardiovascular Devices Market, Japan, Market Share of Major Players (%), 2019
Figure 38: Wound Care Management Market, Japan, Revenue ($B), 2017-2025
Figure 39: Wound Care Management Market, Japan, Market Share of Major Players (%), 2019
Figure 40: Nephrology and Urology Devices Market, Japan, Revenue ($B), 2017-2025
Figure 41: Nephrology and Urology Devices Market, Japan, Market Share of Major Players (%), 2019
Figure 42: Diagnostics Market, Japan, Revenue ($B), 2015-2020
Figure 43: Diagnostics Market, Japan, Revenue Forecast ($B), 2021-2025
Figure 44: Medical Devices Market, Revenue ($B) of Major Companies, Japan, 2019
Figure 45: Deal Value and Deal Count, Pharmaceutical Market, Japan, 2020-2021
Figure 46: Deal Value and Deal Count Sub-types, Pharmaceutical Market, Japan, 2020-2021
Figure 47: Deal Value and Deal Count, Quarterly, Pharmaceutical Market, Japan, 2020-2021
Figure 48: Top Five Therapy Areas by Deal Value, Pharmaceutical Market, Japan, 2020-2021
Figure 49: Top Five Therapy Areas by Deal Count, Pharmaceutical Market, Japan, 2020-2021
Figure 50: M&A Deals by Therapy Area, Pharmaceutical Market, Japan, 2020-2021 (by Value ($M) and by Number)
Figure 51: VC Deals by Therapy Area, Pharmaceutical Market, Japan, 2020-2021 (by Value ($M) and by Number)
Figure 52: Medical Devices Market Deals by Deal Value ($M), Japan, 2020-2021
Figure 53: Medical Devices Market Deals by Deal Count, Japan, 2020-2021
Figure 54: Medical Devices Market Deals Share by Deal Value, Japan, 2020-2021
Figure 55: Medical Devices Market Deals Share by Deal Count, Japan, 2020-2021
  • Global Prenatal Vitamin Ingredients Sales Market Report 2021
    Published: 11-Jun-2021        Price: US 4000 Onwards        Pages: 146
    Market Analysis and Insights: Global Prenatal Vitamin Ingredients Market The global Prenatal Vitamin Ingredients market was valued at US$ 51370 in 2020 and will reach US$ 63150 million by the end of 2027, growing at a CAGR of 3.5% during 2022-2027. Global Prenatal Vitamin Ingredients Scope and Market Size The global Prenatal Vitamin Ingredients market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants......
  • Global Specialty Supplements Sales Market Report 2021
    Published: 11-Jun-2021        Price: US 4000 Onwards        Pages: 144
    A specialty supplement is a formula that has been specially designed to support a specific structure/function application in the body - such as joint health and immune support. Some are single-ingredient products. Others are combination formulas, providing unique blends of complementary ingredients that scientific research has shown work synergistically in the body to illicit similar pharmacological effects. Market Analysis and Insights: Global Specialty Supplements Market ......
  • Global Letter Vitamins Sales Market Report 2021
    Published: 11-Jun-2021        Price: US 4000 Onwards        Pages: 148
    A vitamin is an organic molecule (or related set of molecules) that is an essential micronutrient that an organism needs in small quantities for the proper functioning of its metabolism. Essential nutrients cannot be synthesized in the organism, either at all or not in sufficient quantities, and therefore must be obtained through the diet. Vitamin C can be synthesized by some species but not by others; it is not a vitamin in the first instance but is in the second. Market Analysis......
  • Global Curcuminoid Sales Market Report 2021
    Published: 11-Jun-2021        Price: US 4000 Onwards        Pages: 142
    Market Analysis and Insights: Global Curcuminoid Market The global Curcuminoid market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027. Global Curcuminoid Scope and Market Size The global Curcuminoid market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Curcuminoid market will be able to gain the upper hand as th......
  • Global Pet Medicine Sales Market Report 2021
    Published: 11-Jun-2021        Price: US 4000 Onwards        Pages: 136
    Well over half of the triplicate in the United States own a pet -- almost 80 million homes!Man 's best friend took a be the most iconic. But it' s been a dog, cat, horse, bird, fish, or lizard, pets need to be cared for, pet medical is required. Market Analysis and Insights: Global Pet Medicine Market The global Pet Medicine market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027. Global ......
  • Global Large Volume Parenteral (LVP) Market Insights and Forecast to 2027
    Published: 11-Jun-2021        Price: US 4900 Onwards        Pages: 148
    Large volume parenterals or LVPs (sometimes called large volume injections) are aqueous solutions usually supplied in volumes of at least 100 ml with sizes of 250 ml, 500 ml, 1000 ml, 3000 ml, and 5000 ml most common. Directions usually recommend that large quantities be administered. Parenteral preparations are sterile, solid dosage form or pyrogen-free liquids, which contain one or more number of active ingredients boxed in single or multi dose containers. They are meant to be adm......
  • Global Seaweed Powder Market Insights and Forecast to 2027
    Published: 11-Jun-2021        Price: US 4900 Onwards        Pages: 118
    Seaweed powder is made from marine natural seaweed, supplemented by a small amount of marine microalgae. Natural seaweed powder is rich in seaweed polysaccharides, mannitol, amino acids, proteins, vitamins and potassium, iron, calcium, phosphorus, iodine, selenium, cobalt and other trace elements. The global seaweed powder market is dominated by the Asia Pacific region, and North America is the second largest regional market. At present, the main manufacturers of seaweed powder are ......
  • Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Insights and Forecast to 2027
    Published: 11-Jun-2021        Price: US 4900 Onwards        Pages: 111
    Chemotherapy-induced nausea and vomiting (CINV) is a common side-effect of many cancer treatments. Nausea and vomiting are two of the most feared cancer treatment-related side effects for cancer patients and their families. The classification of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs includes 5-HT3 Inhibitors, NK1 Inhibitors and others. The proportion of 5-HT3 Inhibitors in 2017 is about 62%, and the proportion of NK1 Inhibitors in 2017 is about 33%. Market A......
  • Global Cell Culture Protein Surface Coatings Market Insights and Forecast to 2027
    Published: 11-Jun-2021        Price: US 4900 Onwards        Pages: 115
    The cell culture protein surface coating is a technique in which the cell culture surfaces are coated with extracellular matrix or proteins components to improve the proliferation and adhesion of the cells in vitro. In the last several years, global market of Cell Culture Protein Surface Coatings developed rapidly, with an average growth rate of 13.7%. Market Analysis and Insights: Global Cell Culture Protein Surface Coatings Market The global Cell Culture Protein Su......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs